Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has agreed to acquire Melt Pharmaceuticals, Inc., a clinical-stage company ...
Poster on data from a 611-patient study featuring Imprimis’s MKO Melt to be presented SAN DIEGO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmic-focused division of Imprimis ...
NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results